HK$17.62-15.45% · 3M
Moving avg
1W+2.56%
1M+1.32%
3M-12.60%
6M-24.83%
YTD-28.32%
1Y-43.31%
3Y+154.62%
5Y+136.83%
52-week range
$1.8913% of range$4.69
Company health
Value5/6
Growth6/6
Profitability6/6
Health6/6
Dividend5/6
Bull vs bear
Strengths
- Reasonably valued at 4.3x earnings
- Strong 48% net margin
- High return on equity (3896%)
- Revenue compounding 28% a year
- Net cash on the balance sheet
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$5.62B
Enterprise value
$3.46B
P/E ratio (TTM)
4.32x
P/S ratio (TTM)
2.08x
EV/EBITDA
2.48x
Per share & returns
EPS (TTM)
$0.43
Dividend yield
1.46%
Beta (1Y)
0.48
30-day change
+1.32%
Trading
Volume (24h)
14.64M
Previous close
HK$17.79
Shares outstanding
2.50B
About 3SBio Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
HKEX
Symbol
1530.HK
3SBio Inc. is a mid-cap healthcare company in the Biotechnology industry. Its shares are listed on HKEX (China) and trade under the ticker 1530.HK.
Frequently asked questions
What is 3SBio Inc.'s market cap?
3SBio Inc. (1530.HK) has a market capitalization of $5.62B.
What is 3SBio Inc.'s P/E ratio?
3SBio Inc. trades at a price-to-earnings (P/E) ratio of 4.32.
What exchange does 1530.HK trade on?
1530.HK trades on HKEX.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.58B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.14B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.86B cap